Our finding that loss of Usp22 drastically hampers tumor formation in MMTV-NIC mice is consistent with the results of Prokakis et al, who used a similar mouse model wherein ERBB2 expression and Cre were driven by the MMTV promoter, but in separate transgenes. The gene discussed is ERBB2; the disease is neoplasm.